Heparin : From animal organ extract to designer drugMIDDELDORP, S.Thrombosis research. 2008, Vol 122, Num 6, pp 753-762, issn 0049-3848, 10 p.Article

Increased risk for Fetal loss in Carriers of the factor V Leiden mutationMEINARDI, J. R; MIDDELDORP, S; DE KAM, P. J et al.Annals of internal medicine. 1999, Vol 130, Num 9, pp 736-739, issn 0003-4819Article

A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathwaysTANS, G; CURVERS, J; MIDDELDORP, S et al.Thrombosis and haemostasis. 2000, Vol 84, Num 1, pp 15-21, issn 0340-6245Article

Risk factors of arterial cardiovascular complications in patients with prior venous thromboembolismROSHANI, S; LIJFERING, W. M; COPPENS, M et al.Netherlands journal of medicine. 2011, Vol 69, Num 1, pp 27-30, issn 0300-2977, 4 p.Article

Activation of coagulation system during air travel : a crossover study. CommentarySTRICKER, Hans; SCHREIJER, A. J. M; CANNEGIETER, S. C et al.Lancet (British edition). 2006, Vol 367, Num 9513, issn 0140-6736, 792-793,832-838 [9 p.]Article

Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysisMEINARDI, J. R; MIDDELDORP, S; DE KAM, P. J et al.Blood coagulation & fibrinolysis. 2001, Vol 12, Num 8, pp 713-720, issn 0957-5235Article

Acute myocardial infarction with large bilateral intracoronary thrombi in a young patient with the prothrombin 20210 G- > A mutationDE WINTER, R. J; MIDDELDORP, S; GAFFAR, S et al.Catheterization and cardiovascular diagnosis. 1998, Vol 44, Num 4, pp 427-430, issn 0098-6569Article

Factor V:Q⁵⁰⁶ mutation : Resistance to activated protein C (APC) : Clinical implications with respect to family screeningMIDDELDORP, S; VAN DER MEER, J.Seminars in thrombosis and hemostasis. 1998, Vol 24, Num 4, pp 363-366, issn 0094-6176Article

Development in anticoagulant therapyVAN DOORMAAL, F. F; BÜLLER, H. R; MIDDELDORP, S et al.Critical reviews in oncology/hematology. 2008, Vol 66, Num 2, pp 145-154, issn 1040-8428, 10 p.Article

A retrospective analysis of patients treated for superficial vein thrombosisWICHERS, I. M; HAIGHTON, M; BÜTLER, H. R et al.Netherlands journal of medicine. 2008, Vol 66, Num 10, pp 423-427, issn 0300-2977, 5 p.Article

Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives : a cross-over studyMIDDELDORP, S; MEIJERS, J. C. M; VAN DEN ENDE, A. E et al.Thrombosis and haemostasis. 2000, Vol 84, Num 1, pp 4-8, issn 0340-6245Article

The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosisMIDDELDORP, S; HENKENS, C. M. A; KOOPMAN, M. M. W et al.Annals of internal medicine. 1998, Vol 128, Num 1, pp 15-20, issn 0003-4819Article

Travel and venous thrombosis : a systematic reviewKUIPERS, S; SCHREIJER, A. J. M; CANNEGIETER, S. C et al.Journal of internal medicine. 2007, Vol 262, Num 6, pp 615-634, issn 0954-6820, 20 p.Article

Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: A randomized cross-over study of two low-dose oral contraceptivesMEIJERS, J. C. M; MIDDELDORP, S; TEKELENBURG, W et al.Thrombosis and haemostasis. 2000, Vol 84, Num 1, pp 9-14, issn 0340-6245Article

Monitoring therapy with vitamin K antagonists in patients with Lupus anticoagulant : Effect on different tests for INR determinationBIJSTERVELD, N. R; MIDDELDORP, S; BERENDS, F et al.Journal of thrombosis and thrombolysis. 2000, Vol 9, Num 3, pp 263-269, issn 0929-5305Article

Low-dose oral contraceptives and acquired resistance to activated protein C : a randomised cross-over studyROSING, J; MIDDELDORP, S; CURVERS, J et al.Lancet (British edition). 1999, Vol 354, Num 9195, pp 2036-2040, issn 0140-6736Article